financetom
Business
financetom
/
Business
/
Decisive Dividend Corporation Reports Financial Results For Q4 and Year Ending Dec. 31, 2023
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Decisive Dividend Corporation Reports Financial Results For Q4 and Year Ending Dec. 31, 2023
Mar 20, 2024 2:26 PM

05:11 PM EDT, 03/20/2024 (MT Newswires) -- Decisive Dividend Corporation ( DEDVF ) Wednesday reported its financial results for the fourth quarter and year ending Dec. 31, 2023.

Highlights show consolidated sales increased 16% to $35.7 million in Q4 2023 compared to $30.8 million in Q4 2022; the quarterly sales increase brought consolidated annual sales for 2023 to $134.9 million, an increase of $36.3 million, or 37%, relative to 2022.

The annual net profit of $8.3 million, or $0.48 per share, in 2023, represents an increase of $4.2 million, or $0.17 per share, compared to 2022.

The per share monthly dividend increased twice in 2023 and again in March 2024 to $0.045 per share, representing an aggregate increase of 50% in the annualized per share dividend over the last year.

Price: 0.11, Change: -0.07, Percent Change: -0.63

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
SEI Investments CFO Sean Denham Adds Operations Chief Role
SEI Investments CFO Sean Denham Adds Operations Chief Role
Feb 25, 2025
09:39 AM EST, 02/25/2025 (MT Newswires) -- SEI Investments ( SEIC ) said Tuesday that Chief Financial Officer Sean Denham will expand his role to chief financial and chief operating officer. Besides performing his responsibilities as CFO, Denham will oversee SEI Investments' ( SEIC ) information technology, operations, and human resources functions, the company said. Price: 80.30, Change: +0.28, Percent...
Arbutus Biopharma Names Lindsay Androski CEO, Overhauls Board
Arbutus Biopharma Names Lindsay Androski CEO, Overhauls Board
Feb 25, 2025
09:35 AM EST, 02/25/2025 (MT Newswires) -- Arbutus Biopharma ( ABUS ) said Tuesday it has named Lindsay Androski as chief executive, effective immediately. The company said Androski succeeds interim CEO and President Michael J. McElhaugh, and will join the company's board. Androski is a special counsel at Genevant, Arbutus said. All existing board members have stepped down from their...
QXO Extends Tender Offer Period to Acquire Beacon Roofing Supply
QXO Extends Tender Offer Period to Acquire Beacon Roofing Supply
Feb 25, 2025
09:41 AM EST, 02/25/2025 (MT Newswires) -- QXO (QXO) said Tuesday that its all-cash tender offer to acquire all outstanding Beacon Roofing Supply's ( BECN ) shares for $124.25 apiece will now expire on Monday, March 3, at 5 pm ET, rather than Feb. 24. QXO said it is confident Beacon stockholders will overwhelmingly support the offer. Separately, Beacon said...
Thermo Fisher Bets Big On Bioproduction With Solventum's Unit Deal Worth $4.1 Billion
Thermo Fisher Bets Big On Bioproduction With Solventum's Unit Deal Worth $4.1 Billion
Feb 25, 2025
On Tuesday, Thermo Fisher Scientific Inc. ( TMO ) agreed to acquire Solventum’s Purification & Filtration business for approximately $4.1 billion in cash. Solventum’s Purification & Filtration business provides purification and filtration technologies for the production of biologics, medical technologies and industrial applications. The Solventum ( SOLV ) business operates globally, with sites in the Americas, Europe, the Middle East, Africa and...
Copyright 2023-2026 - www.financetom.com All Rights Reserved